首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity
【24h】

Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity

机译:8-氨基-1,3-二甲基嘌呤-2,6-二酮的芳基哌嗪烷基氧化物作为具有潜在抗精神病药的新型多元靶的5-HT / D受体剂

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new 7-arylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 8-amino substituent in 8 position was synthesized and their 5-HT1A, 5-HT2A, 5-HT6, 5-HT7, and D-2 receptor affinities were determined. The binding study allowed identifying some potent 5-HT1A/5-HT2A/5-HT7/D-2 ligands. The most interesting because of their multireceptor profile were 8-piperidine (30-35) and 8-dipropylamine (45-47) analogs with four and five carbon aliphatic linkers. The selected compounds 24, 31, 34, 39, 41, 43, 45, and 46 in the functional in vitro evaluation for all targeted receptors showed significant partial D-2 agonist, partial 5-HT1A agonist, and 5-HT2A antagonist properties. The advantageous in vitro affinity of compound 34 for 5-HT1A and D-2 receptors has been explained by means of molecular modeling, taking into consideration its partial agonist activity towards the latter one. In behavioral studies, compounds 32 and 34 revealed antipsychotic-like properties, significantly decreasing D-amphetamine-induced hyperactivity in mice.
机译:一系列新的7-芳基哌嗪基烷基-1,3-二甲基 - 嘌呤-2,6-二酮衍生物,其中8个位置具有多样化的8-氨基取代基,其5-HT1A,5-HT2A,5-HT6,5-HT7和D-2受体亲和力确定。结合研究允许鉴定一些有效的5-HT1A / 5-HT2A / 5-HT7 / D-2配体。由于其多人轮廓最有趣的是8-哌啶(30-35)和8-二丙胺(45-47)类似物,具有四和五种碳脂族接头。在所有靶向受体的功能体外评估中所选化合物24,31,34,39,41,43,45和46显示出显着的部分D-2激动剂,部分5-HT1A激动剂和5-HT2A拮抗性。通过分子建模已经解释了化合物34对5-HT1A和D-2受体的有利的体外亲和力,考虑到其部分激动剂活性向后者进行解释。在行为研究中,化合物32和34揭示了抗精神病的性质,显着降低小鼠中的D- amphetamine诱导的多动。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号